Publications by authors named "Marc-Oliver Grimm"

88Publications

SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells.

Authors:

Roland Kotolloshi Martin Hölzer Mieczyslaw Gajda Marc-Oliver Grimm Daniel Steinbach

Cells 2021 Jan 6;10(1). Epub 2021 Jan 6.

Department of Urology, Jena University Hospital, 07740 Jena, Germany.

View Article and Find Full Text PDF

January 2021

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial.

ESMO Open 2020 11;5(6)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article and Find Full Text PDF

November 2020

Re: Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.

Authors:

Marc-Oliver Grimm Katharina Leucht

Eur Urol 2020 Nov 1. Epub 2020 Nov 1.

Department of Urology, Jena University Hospital, Jena, Germany. Electronic address:

View Article and Find Full Text PDF

November 2020

Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.

Authors:

Michael Staehler Michael Stöckle Daniel C Christoph Arnulf Stenzl Karin Potthoff Marc-Oliver Grimm Dunja Klein Johanna Harde Fabian Brüning Peter J Goebell Marinela Augustin Frederik Roos Iris Benz-Rüd Norbert Marschner Viktor Grünwald

Int J Cancer 2020 Oct 18. Epub 2020 Oct 18.

Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, University Hospital Hannover Medical School, Hannover, Germany.

View Article and Find Full Text PDF

October 2020

Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.

Authors:

Peter J Goebell Philipp Ivanyi Jens Bedke Lothar Bergmann Dominik Berthold Martin Boegemann Jonas Busch Christian Doehn Susanne Krege Margitta Retz Gunhild von Amsberg Marc-Oliver Grimm Viktor Gruenwald

Future Oncol 2020 Oct 23;16(29):2307-2328. Epub 2020 Sep 23.

Interdisciplinary GU Oncology, Clinic for Medical Oncology & Clinic for Urology, University Hospital Essen, D-45147, Essen, Germany.

View Article and Find Full Text PDF

October 2020

Reply to Emre Karabay and İlker Tınay's Letter to the Editor re: Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS". Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.066.

Authors:

Marc-Oliver Grimm Christien Caris Wim P J Witjes

Eur Urol 2020 10 18;78(4):e163-e164. Epub 2020 Jul 18.

EAU Research Foundation, Arnhem, The Netherlands.

View Article and Find Full Text PDF

October 2020

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial.

J Immunother Cancer 2020 Jul;8(2)

Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.

View Article and Find Full Text PDF

July 2020

Position Paper of the German Society for Interventional Radiology (DeGIR) on Prostatic Artery Embolization.

Authors:

Attila Kovács Arno Bücker Marc-Oliver Grimm Christian R Habermann Marcus Katoh Alexander Massmann Andreas H Mahnken Bernhard C Meyer Michael Moche Peter Reimer Ulf Teichgräber Frank K Wacker

Rofo 2020 Sep 2;192(9):835-846. Epub 2020 Jul 2.

Hannover Medical School, Department of Diagnostic and Interventional Radiology, Hannover, Germany.

View Article and Find Full Text PDF

September 2020

A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society.

Authors:

Lothar Bergmann Viktor Grünwald Luise Maute Marc-Oliver Grimm Steffen Weikert Jan Schleicher Theodor Klotz Jochen Greiner Anne Flörcken Arndt Hartmann Thomas Gauler

Oncol Res Treat 2020 15;43(7-8):333-339. Epub 2020 Jun 15.

Department of Medical Oncology, West German Cancer Center, University Hospital Essen of the University Duisburg-Essen, Essen, Germany.

View Article and Find Full Text PDF

September 2020

Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies.

Authors:

Christoph Werner Olaf Dirsch Uta Dahmen Marc-Oliver Grimm Stefan Schulz Amelie Lupp

Transl Oncol 2020 Sep 24;13(9):100801. Epub 2020 May 24.

Institute of Pharmacology and Toxicology, Jena University Hospital, Jena, Germany. Electronic address:

View Article and Find Full Text PDF

September 2020

Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS".

Authors:

Marc-Oliver Grimm Antoine G van der Heijden Marc Colombel Tim Muilwijk Luis Martínez-Piñeiro Marko M Babjuk Levent N Türkeri Joan Palou Anup Patel Anders S Bjartell Christien Caris Raymond G Schipper Wim P J Witjes

Eur Urol 2020 Nov 20;78(5):690-698. Epub 2020 May 20.

EAU Research Foundation, Arnhem, The Netherlands.

View Article and Find Full Text PDF

November 2020

Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor Therapy.

Authors:

Ioana Plesca Antje Tunger Luise Müller Rebekka Wehner Xixi Lai Marc-Oliver Grimm Sergio Rutella Michael Bachmann Marc Schmitz

Front Immunol 2020 4;11:364. Epub 2020 Mar 4.

Faculty of Medicine Carl Gustav Carus, Institute of Immunology, TU Dresden, Dresden, Germany.

View Article and Find Full Text PDF

March 2020

Erratum zu: Nierenzellkarzinom.

Authors:

Marc-Oliver Grimm Christian Doehn Susanne Krege

Urologe A 2020 Apr;59(4):487

Klinik für Urologie, Kinderurologie und urologische Onkologie, Kliniken Essen-Mitte, Evang. Huyssens Stiftung/Knappschaft GmbH, Henricistr. 92, 45136, Essen, Deutschland.

View Article and Find Full Text PDF

April 2020

High Detection Rate for Non-Muscle-Invasive Bladder Cancer Using an Approved DNA Methylation Signature Test.

Authors:

Daniel Steinbach Michael Kaufmann Juliane Hippe Mieczyslaw Gajda Marc-Oliver Grimm

Clin Genitourin Cancer 2020 06 17;18(3):210-221. Epub 2019 Oct 17.

Department of Urology, Jena University Hospital, Jena, Germany.

View Article and Find Full Text PDF

June 2020

New First Line Treatment Options of Clear Cell Renal Cell Cancer Patients with PD-1 or PD-L1 Immune-Checkpoint Inhibitor-Based Combination Therapies.

Authors:

Marc-Oliver Grimm Katharina Leucht Viktor Grünwald Susan Foller

J Clin Med 2020 Feb 19;9(2). Epub 2020 Feb 19.

Department of Urology, University Hospital Jena, 07747 Jena, Germany.

View Article and Find Full Text PDF

February 2020

[Renal cell carcinoma].

Authors:

Marc-Oliver Grimm Christian Doehn Susanne Krege

Urologe A 2020 Feb;59(2):133-134

Klinik für Urologie, Kinderurologie und urologische Onkologie, Kliniken Essen-Mitte, Evang. Huyssens Stiftung/Knappschaft GmbH, Henricistr. 92, 45136, Essen, Deutschland.

View Article and Find Full Text PDF

February 2020

Prostatic Artery Embolization-Anatomic Predictors of Technical Outcomes.

Authors:

Georg Friedrich Enderlein Thomas Lehmann Friedrich-Carl von Rundstedt René Aschenbach Marc-Oliver Grimm Ulf Teichgräber Tobias Franiel

J Vasc Interv Radiol 2020 Mar 15;31(3):378-387. Epub 2019 Nov 15.

Institut für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Jena, Jena, Germany.

View Article and Find Full Text PDF

March 2020

The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy.

Authors:

Antje Tunger Ulrich Sommer Rebekka Wehner Anne Sophie Kubasch Marc-Oliver Grimm Michael Philipp Bachmann Uwe Platzbecker Martin Bornhäuser Gustavo Baretton Marc Schmitz

J Clin Med 2019 Sep 25;8(10). Epub 2019 Sep 25.

National Center for Tumor Diseases (NCT), University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307 Dresden, Germany.

View Article and Find Full Text PDF

September 2019

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial.

Lancet Oncol 2019 10 16;20(10):1370-1385. Epub 2019 Aug 16.

Department of Genitourinary Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF

October 2019

Safe Use of Immune Checkpoint Inhibitors in the Multidisciplinary Management of Urological Cancer: The European Association of Urology Position in 2019.

Authors:

Marc-Oliver Grimm Axel Bex Maria De Santis Börje Ljungberg James W F Catto Morgan Rouprêt Syed A Hussain Joaquim Bellmunt Tom Powles Manfred Wirth Hendrik Van Poppel

Eur Urol 2019 Sep 21;76(3):368-380. Epub 2019 Jun 21.

Department of Urology, University Hospitals Leuven, Leuven, Belgium.

View Article and Find Full Text PDF

September 2019